Influenza Diagnostics Industry Analysis: Market Size, Growth Trends, and Forecast to 2031

The Global Influenza Diagnostics Market is poised for significant growth, driven by increasing prevalence of influenza and advancements in diagnostic technologies. Valued at US$ 1.3 billion in 2022, the market is projected to grow at a CAGR of 5.6% during 2023–2031, reaching over US$ 2.0 billion by the end of the forecast period.

Download to explore critical insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17435

Market Dynamics

Global Overview of Influenza Diagnostics

Influenza, a highly contagious respiratory infection caused by influenza viruses, significantly impacts global public health. The viruses, classified into types A, B, C, and D, primarily cause seasonal outbreaks and pandemics through influenza A and B.

Accurate diagnostics play a critical role in identifying infections promptly, ensuring effective patient management, and controlling outbreaks. Various methods such as polymerase chain reaction (PCR), rapid antigen tests, viral cultures, and serological assays are commonly used.

Molecular techniques, including RT-PCR, offer high sensitivity and specificity, enabling accurate detection of viral RNA within hours. Rapid diagnostic tests (RDTs), though faster, may lack sensitivity in comparison.

Rising Prevalence of Influenza

Globalization, urbanization, and high population density have intensified the transmission rates of influenza. According to the World Health Organization (WHO), seasonal influenza results in 1 billion cases annually, including 3–5 million severe cases and 290,000–650,000 respiratory deaths.

Increased mobility and densely populated urban areas have exacerbated the spread of the virus. The dynamic nature of influenza viruses, driven by frequent mutations and antigenic drift, further complicates the situation, rendering populations susceptible to reinfections.

The growing burden of influenza necessitates robust diagnostic solutions for timely disease management, thus propelling the growth of the global influenza diagnostics market.

Demand for Rapid Diagnostic Tests (RDTs)

RDTs have emerged as a key driver of market growth due to their ability to deliver results within minutes. Their user-friendly design enables decentralized testing in remote and resource-constrained regions, making them invaluable during outbreaks and pandemics.

The cost-effectiveness of RDTs further enhances their adoption, catering to the economic considerations of healthcare providers and patients. These attributes position RDTs as essential tools in influenza diagnostics.

Dominance of RT-PCR Tests

RT-PCR tests accounted for the largest share of the global influenza diagnostics market in 2022. With exceptional accuracy and rapid turnaround time, RT-PCR tests enable precise identification of influenza A and B subtypes, facilitating appropriate treatment and public health responses.

Governments worldwide are actively promoting RT-PCR as a primary diagnostic tool. For instance, India's Integrated Disease Surveillance Programme (IDSP) emphasizes RT-PCR in its influenza control strategy.

A study by the Centers for Disease Control and Prevention (CDC) highlights the advantages of RT-PCR, reporting a 98.7% sensitivity for influenza A and B detection compared to 78.1% for rapid influenza diagnostic tests (RIDTs).

Buy this Premium Research Report to stay ahead with cutting-edge data - https://www.transparencymarketresearch.com/influenza-diagnostics-market.html

Regional Outlook

North America: Market Leader

North America dominated the global influenza diagnostics market in 2022, driven by advanced healthcare infrastructure, high disease burden, and strong public health surveillance systems.

In the U.S., an average of 13.5 million annual influenza cases underlines the need for sophisticated diagnostic tools. Well-equipped hospitals and widespread adoption of electronic health records further bolster the market.

Asia Pacific: Rapid Growth Potential

Asia Pacific is expected to witness the fastest growth during 2023–2031. Factors such as increasing healthcare awareness, rising influenza burden, aging populations, and government initiatives drive this growth. Expanding diagnostic capabilities and proactive healthcare policies position the region as a promising market for influenza diagnostics.

Competitive Landscape

Prominent players in the global influenza diagnostics market include:

• 3M
• Abbott
• F. Hoffmann-La Roche Ltd.
• Becton, Dickinson and Company
• BIOMÉRIEUX
• Bio-Rad Laboratories, Inc.
• Goldsite Diagnostics, Inc.
• Hologic, Inc.
• DiaSorin S.p.A.
• Meridian Bioscience, Inc.
• QuidelOrtho Corporation
• Siemens Healthineers
• Thermo Fisher Scientific

Key Developments

• In August 2023, Goldsite Diagnostics announced that its products are registered with the UK Medicines & Healthcare products Regulatory Agency (MHRA). These include Influenza A/B Antigen Rapid Test Kits and combination test kits for SARS-CoV-2 and influenza.
• In April 2023, the WHO launched the Preparedness and Resilience for Emerging Threats Initiative (PRET) to strengthen countries' responses to respiratory pathogens such as influenza.

Explore Latest Research Reports by Transparency Market Research:

Sample Preparation Market: The global sample preparation market was worth US$ 5,644.3 Mn and is projected to reach a value of US$ 10,035.8 Mn by the end of 2027

Acupuncture Needles Market:  The global acupuncture needles market was worth US$ 114.8 Mn and is projected to reach a value of US$ 200 Mn by the end of 2031

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com    
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube